Introduction
Chronic ulcer treatment, mainly in case of venous ulcers, represents a considerable strain for health services (1) (2) . Specialized human resources and adjuvant therapies are needed, which are frequently adopted for lengthy treatment. In addition, this type of lesion often affects the patient's functional capacity, causing multidimensional consequences -social, psychological, financial (3) .
Venous ulcers represent the most advanced stage of chronic venous insufficiency. The global prevalence rate ranges between 0.5 and 2%, and surpasses 4% in individuals over 65 years of age. Incidence rates vary between two and five new cases per thousand people per year (4) (5) .
Studies developed in recent years have contributed to an important increase in the availability of new wound healing products (6) (7) (8) (9) . Papain dressings have been studied in different formulations and concentrations as an option in venous ulcer treatment (10) .
In a systematic review aimed at analyzing evidence on the use of papain in the wound healing process, the results appointed the lack of a standard form and presentation to use the product, besides the predominance of low-quality research according to the international assessment scales, indicating the need to develop research with stricter methods for the sake of a more precise assessment of the effectiveness of papain in the tissue repair process (11) .
The study objective was to assess the effectiveness of 2% papain gel compared to 2% carboxymethyl cellulose in the treatment of chronic venous ulcer patients.
Method
A Randomized Controlled Clinical Trial (RCCT) was developed at a specialized outpatient clinic in wound treatment of a teaching hospital in the State of Rio de Janeiro, Brazil.
The consecutive sample consisted of all male and female individuals who complied with the inclusion criteria, which were: age ≥18 years; presence of one or more venous leg ulcers with a minimum length of six weeks; indication to use 2% papain gel and 2%
carboxymethyl cellulose gel; demonstrate understanding of the health team's orientations to guarantee the continuity of the treatment at home or having a legal responsible to do so; availability to visit the clinic once per week; being regularly registered at the institution where the research was undertaken.
Patients were excluded in the following cases:
infected ulcer, associated with erysipelas, cellulitis or lymphangitis, ulcer with the presence of devitalized tissue covering the entire wound bed; with circular lower-limb lesions, with non-palpable distal pulse; without appropriate conditions to store the products at home; patients with a background history of alcoholism or psychiatric diseases, individuals allergic to any of the products used in the research and/or to latex; patients with liver and/or kidney problems.
The criteria for discontinuity were: presence of wound infection during follow-up, use of another product on the wound than that proposed in the research, occurrence of severe adverse events and not participating in weekly outpatient appointments. The patients who agreed to participate in the study and signed the Informed Consent Form were randomized and allocated to two groups: Trial Group (TG) and Control Group (CG). In the Trial Group, the ulcer dressing was applied using 2% papain gel and, in the Control Group, the product used was 2% carboxymethyl cellulose gel.
For the sake of randomization, a research collaborator used a table with random figures. The study participants were only informed about which group the patient would be allocated to at the moment of each volunteer's first consultation.
In those situations when the patient had more than one lesion, all injuries were treated with the same product, according to the patient's allocation in the study.
The 2% papain gel was formulated using papain, EDTA, propylene glycol, carbopol 940, preservatives and To assess the wounds, the Assessment Protocol for Clients with Tissue Injuries was used, an instrument used at the outpatient clinic which resulted from a research (12) . According to the protocol, the type of tissue was classified as granulation, epithelialization, slough and coagulation necrosis, and the amount of each tissue was registered as: absent; between 1 and 25%; between 26 and 50%; between 51 and 75% and between 76 and 100% of the total lesion area. To assess the effectiveness of the product to treat the lesions, the amount of each tissue was compared in the first and final week of follow-up.
As regards the exudate, the amount was assessed as: absent, when the wound bed was dry; little, when the wound bed was moist and involved drainage of at least 25% of the dressing; moderate, when the wound bed was saturated and the drainage involved between 25 and 75% of the dressing; and great, when the wound bed was covered with fluid and the drainage involved more than 75% of the dressing (13) (14) .
The participants were assessed weekly and the planimetric records and photograph of the lesion were taken every two weeks. During the first visit, the data were collected on the patient's sociodemographic and health conditions. The researchers changed the dressing once per week at the wound clinic and the patients changed it daily at home. To apply the dressing at home, the patients received preliminary orientations, including information leaflets, on the dressing, storage and transportation of the products. Two nurse researchers performed the procedures for the two treatment groups.
The patients from the Trial and Control Groups received the material needed for the daily dressing change, the "dressing kit". This kit included a tube with 2% papain gel or 2% carboxymethyl cellulose gel, gauze, bandage, adhesive tape, 0.9% saline solution, soothing solution for the skin surrounding the lesion and a recipient to transport the product.
The length of the follow-up was 77 days/12 weeks, defined based on the mean number of days of international clinical experimental trials involving chronic ulcer patients (15) (16) .
The blinding of the participants and researchers was compromised due to the product characteristics, such as refrigeration of the papain gel at 4ºC and 
Results

Eighteen patients participated in the research, including ten in the Trial Group and eight in the Control
Group, totaling 28 ulcers that were treated during 12 weeks.
The Trial Group and the Control Group were homogeneous in terms of the sociodemographic and health characteristics, as presented in Table 1 .
The patients' age ranged between 45 and 85 years, with a mean age of 61.94 years and standard deviation ±12.5. In the 18 participants, 28 venous ulcers were identified, as there were patients with more than one injury, and five was the largest number of injuries in the same patient. Sixteen lesions were included in the Trial Group and 12 in the Control Group.
As regards the characteristics of the venous ulcers, the majority started more than ten years earlier (53.6%), 3.6% between 7 and 10 years, 32. Rodrigues ALS, Oliveira BGRB, Futuro DO, Secoli SR. To assess when the main variation took place among the treatment weeks in the Trial Group, multiple comparisons were made among the lesion areas, considering different pairs of treatment weeks (Table 2) .
In Table 2 , a significant difference was observed between the lesion area in different treatment intervals.
After the use of Dunn's test and the correction of the adjusted p-value, the main variation was found between the fifth and the twelfth week (adjusted p-value=0.032), which indicates that, at this moment in the treatment, a statistically significant reduction took place in the area of the lesions treated with 2% papain gel. 
Discussion
The analysis of the sociodemographic data showed the prevalence of retired people, as 22.2% of the sample were disability retirees, due to the chronic ulcers, which can cause the early distancing from work life, affect the quality of life and put a relevant strain on the country's health and social security systems.
The low level of education, associated with the participants' precarious socioeconomic condition, contributes to the reduced access to information on the prevention and care in venous ulcer treatment. It
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should be highlighted that all study participants suffered from chronic venous insufficiency: 61.1% suffered from systemic arterial hypertension and 11.1% from diabetes mellitus. These factors reveal the need for a highquality public health service that offers treatment and monitoring to the patients, so that they turn into active agents of their health condition (17) .
In the assessment of chronic venous ulcers, two items serve as significant predictors of healing, the area and how long the lesion has existed. The area of the lesions in this study is in accordance with the Brazilian standard, with 89.3% of the ulcers measuring 26cm 2 or less (18) (19) . International studies consider wounds as large when measuring 10cm 2 or more (15) . The Brazilian classification of wound areas is different though, with wounds measuring less than 50cm 2 being considered small; between 50cm 2 and 150cm 2 medium; between In a study developed in the USA that involved 165 venous ulcer patients and 12 weeks of monitoring, it was verified that, in cases of large and lengthy ulcers, rapid healing is impossible (21) . Another study evidenced that a good prognosis of venous ulcers depends directly on the size and evolution time of the ulcer. A wound measuring less than 10cm 2 with an evolution time of less than 12 months has 71% chance of healing by the 24 th week of treatment, while wounds larger than 10cm 2 with an evolution time of more than 12 months have a 22% chance of cure (22) .
The results demonstrated that the venous ulcers range of wounds, instead of leg ulcer treatment (23) .
The Control Group that used the 2% carboxymethyl cellulose gel on the venous ulcers did not demonstrate a significant reduction in the lesion area (p-value=0.408)
over the 12 weeks of treatment. In a review on the use of carboxymethyl cellulose dressings, evidence was found that suggests that these dressings are more effective in the healing of diabetic ulcers than other dressings, but this finding is doubtful due to the risk of bias in the original studies (24) . (25) .
As regards the healthy tissue, the research data were favorable, with an increase in the amount of granulation tissue in the Trial Group (p-value=0.021)
as well as in the Control Group (p-value=0.031). The increase in the granulation tissue was also observed in an international study of wounds treated using a product that associates papain and urea in comparison to wounds treated with collagenase (23) .
Only the Trial Group showed a significant increase (p-value=0.004) in the amount of epithelialized tissue during the treatment. Therefore, 2% papain gel showed a superior result to 2% CMC gel in this healing phase.
The epithelialized tissue leads to the contraction and, consequently, the closure of the wound. An increase in this tissue indicates that the treatment used is favoring the tissue repair process (25) .
The amount of exudate in the two treatment groups varied between little and moderate in most lesions, without any significant change between the first and last treatment week. The lesser the amount of exudate, the better the healing conditions are, in view of the PUSH score (13) . An excessive quantity of exudate is associated with the critical colonization of the wound surface, with a systemic infection or persistent inflammation of the wound (25) . In a Brazilian study, most patients (60.0%)
showed a moderate to large quantity of exudate (19) , differing from the result found in this research.
Conclusion
After assessing the effectiveness of 2% papain gel compared to 2% carboxymethyl cellulose gel to treat
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chronic venous ulcers, it is concluded that the 2% papain gel was more effective concerning the primary outcome of this research, with a significant reduction in the lesion area in that group, particularly between the fifth and twelfth week of treatment.
As regards the secondary outcome, the reduction of exudate, no significant change was found between the groups, as the patients presented a little to moderate amount of exudate between the onset and end of the treatment, which is a positive characteristic of the group of patients attended at the Wound Clinic.
As regards the outcome reduction of devitalized tissue in the ulcer bed, the result was significant in the In view of the importance of the theme, this study can contribute to the development of research protocols for wound assessment. Multicenter studies are needed to deepen the investigation of variables related to the effectiveness of papain gel.
